Another protein of the B7 family of checkpoints, B7H3, has the highest expression compared to other members of the B7 family in GBM (current nomenclature is WHO grade IV diffuse glioma) as shown by Zhang et al. This evidence concerns the gene CD276 and glioblastoma.